| # | Drug | Count |
|---|---|---|
| 0 | TACROLIMUS | 247 |
| 1 | TACROLIMUS EXTENDED-RELEASE CAPSULES | 243 |
| 2 | TACROLIMUS OINTMENT 0.1% | 243 |
| 3 | MYCOPHENOLATE MOFETIL | 203 |
| 4 | MYCOPHENOLATE MOFETIL HYDROCHLORIDE | 203 |
| 5 | METHYLPREDNISOLONE | 140 |
| 6 | PREDNISONE | 140 |
| 7 | DEXAMETHASONE | 96 |
| 8 | DEXAMETHASONE 1.5 MG | 96 |
| 9 | VORICONAZOLE | 86 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | ERAVACYCLINE | 3 | 0.0101 |
| 1 | MICAFUNGIN SODIUM | 48 | 0.0073 |
| 2 | AMPHOTERICIN B | 60 | 0.0047 |
| 3 | THIOGUANINE | 8 | 0.0038 |
| 4 | VANCOMYCIN HYDROCHLORIDE | 28 | 0.0034 |
| 5 | CEFIDEROCOL SULFATE TOSYLATE | 1 | 0.0032 |
| 6 | VORICONAZOLE | 86 | 0.0028 |
| 7 | REMDESIVIR | 36 | 0.0027 |
| 8 | ANTI-THYMOCYTE GLOBULIN (RABBIT) | 22 | 0.0027 |
| 9 | POSACONAZOLE | 43 | 0.0026 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 354 |
| 1 | Azole Antifungal [EPC] | 146 |
| 2 | Alkylating Drug [EPC] | 71 |
| 3 | Polyene Antifungal [EPC] | 69 |
| 4 | Lipid-based Polyene Antifungal [EPC] | 60 |
| 5 | Echinocandin Antifungal [EPC] | 52 |
| 6 | CD20-directed Cytolytic Antibody [EPC] | 48 |
| 7 | Nucleoside Metabolic Inhibitor [EPC] | 45 |
| 8 | Kinase Inhibitor [EPC] | 44 |
| 9 | Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] | 40 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Echinocandin Antifungal [EPC] | 52 | 0.0063 |
| 1 | Lipid-based Polyene Antifungal [EPC] | 60 | 0.0047 |
| 2 | SARS-CoV-2 Nucleotide Analog RNA Polymerase Inhibitor [EPC] | 36 | 0.0027 |
| 3 | Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] | 40 | 0.0018 |
| 4 | Antimetabolite Immunosuppressant [EPC] | 37 | 0.0017 |
| 5 | Polyene Antifungal [EPC] | 69 | 0.0017 |
| 6 | Cytomegalovirus DNA Terminase Complex Inhibitor [EPC] | 4 | 0.0012 |
| 7 | Asparagine-specific Enzyme [EPC] | 15 | 0.0011 |
| 8 | Oxazolidinone Antibacterial [EPC] | 29 | 0.0010 |
| 9 | Azole Antifungal [EPC] | 146 | 0.0009 |